Related Experiment Video
Updated: Feb 8, 2026

Development of a Polymicrobial Colony Biofilm Model to Test Antimicrobials in Cystic Fibrosis
Published on: September 20, 2024
Developments with investigating descriptors for antimicrobial AApeptides and their derivatives
Olapeju Bolarinwa1, Jianfeng Cai1
1a Department of Chemistry , University of South Florida , Tampa , FL , USA.
Antimicrobial AApeptides offer a promising alternative to conventional antibiotics, combating drug-resistant bacteria. These novel peptidomimetics show enhanced activity and stability, addressing limitations of traditional antimicrobial peptides.
Area of Science:
- Biochemistry
- Microbiology
- Drug Discovery
Background:
- Multidrug-resistant bacteria necessitate novel antibiotic strategies.
- Host-defense peptides (HDPs) are natural antimicrobials but have limitations.
- AApeptides are emerging peptidomimetics with improved antimicrobial properties.
Purpose of the Study:
- To review recent advancements in antimicrobial AApeptides.
- To discuss derivatizations and applications of AApeptides.
- To highlight findings on the heterogeneous γ-AA backbone.
Main Methods:
- Literature review of antimicrobial AApeptide research.
- Analysis of AApeptide structure-activity relationships.
- Evaluation of AApeptide mechanisms and therapeutic potential.
Main Results:
- AApeptides exhibit potent, broad-spectrum antimicrobial activity.
- They demonstrate resistance to proteolysis and improved efficacy.
- AApeptides show promise against drug-resistant pathogens.
Conclusions:
- AApeptides are a viable alternative to conventional antibiotics.
- Their design offers limitless structural diversity for antimicrobial applications.
- AApeptides and derivatives hold significant therapeutic potential.
Related Concept Videos
Antimicrobial Effectiveness
Antimicrobial Proteins
Interferons
Interferons (IFNs) are proteins produced by lymphocytes, macrophages, and fibroblasts infected with viruses. While IFNs cannot prevent viruses from entering and...
Measurement: Derived Units
Sustainable Development
Drugs Affecting GI Tract Motility: Antimicrobials as Antidiarrheal Agents
Higher Derivatives

